Diabetic Neuropathy - Pipeline Review, H1 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Diabetic Neuropathy - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

This latest pipeline guide provides comprehensive information on the therapeutics under development for Diabetic Neuropathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Diabetic Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 10, 3, 15 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Companies Mentioned

  • Achelios Therapeutics Inc
  • Angelini Group
  • Arena Pharmaceuticals Inc
  • Bristol-Myers Squibb Co
  • Commence Bio Inc
  • Grifols SA
  • Grunenthal GmbH
  • Immune Pharmaceuticals Inc
  • Kineta Inc
  • Medifron DBT Co Ltd
  • Mitsubishi Tanabe Pharma Corp
  • Neuralstem Inc
  • NovaLead Pharma Pvt Ltd
  • Novaremed Ltd
  • Omeros Corp
  • Reata Pharmaceuticals Inc
  • Relief Therapeutics Holding AG
  • Sphaera Pharma Pte Ltd
  • ViroMed Co Ltd

For more information about this report visit https://www.researchandmarkets.com/research/5c6zqn/diabetic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs